15-82990021-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_031452.4(RAMAC):āc.311A>Gā(p.Tyr104Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000148 in 1,559,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031452.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAMAC | NM_031452.4 | c.311A>G | p.Tyr104Cys | missense_variant | 4/4 | ENST00000304191.4 | NP_113640.1 | |
C15orf40 | NM_001160116.2 | c.367-864T>C | intron_variant | NP_001153588.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAMAC | ENST00000304191.4 | c.311A>G | p.Tyr104Cys | missense_variant | 4/4 | 1 | NM_031452.4 | ENSP00000307181.3 |
Frequencies
GnomAD3 genomes AF: 0.0000564 AC: 8AN: 141750Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000337 AC: 8AN: 237200Hom.: 0 AF XY: 0.00000775 AC XY: 1AN XY: 129000
GnomAD4 exome AF: 0.0000106 AC: 15AN: 1417320Hom.: 0 Cov.: 24 AF XY: 0.00000854 AC XY: 6AN XY: 702884
GnomAD4 genome AF: 0.0000564 AC: 8AN: 141750Hom.: 0 Cov.: 30 AF XY: 0.0000146 AC XY: 1AN XY: 68282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2024 | The c.311A>G (p.Y104C) alteration is located in exon 4 (coding exon 2) of the FAM103A1 gene. This alteration results from a A to G substitution at nucleotide position 311, causing the tyrosine (Y) at amino acid position 104 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at